ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

WBMD Webmd Health Corp

66.48
0.00 (0.00%)
29 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Webmd Health Corp NASDAQ:WBMD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 66.48 66.49 66.50 0 01:00:00

WeissLaw LLP: WebMD Health Corp. Acquisition Is the Subject of a Legal Investigation

25/07/2017 6:23pm

PR Newswire (US)


Webmd Health (NASDAQ:WBMD)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Webmd Health Charts.

NEW YORK, July 25, 2017 /PRNewswire/ -- The fairness of the proposed acquisition of WebMD Health Corp. ("WBMD" or the "Company") (NASDAQ: WBMD) by private equity firm KKR & Co. ("KKR") is the subject of an investigation by WeissLaw LLP, a national class action and shareholder rights law firm.  The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of WBMD for agreeing to sell the Company to KKR.  On July 24, 2017, the Company announced a definitive agreement for KKR to acquire WBMD in a transaction valued at approximately $2.8 billion.  Under the terms of the agreement, WBMD shareholders will receive $66.50 in cash for each WBMD share they own. 

WeissLaw is investigating whether WBMD's Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target price of $72.00 per share, or $5.50 above the offer price.  Additionally, on the same day as the acquisition announcement, WBM preliminarily reported that it expected to exceed its revenue guidance by approximately $3 million at the high-end in the second quarter of 2017.  It also announced that it anticipated annual growth of 6% and 8% in net income and adjusted EBITDA, respectively. 

Given these facts, WeissLaw is investigating whether the WBMD Board acted in the best interests of WBMD's public shareholders by actively shopping the Company to maximize shareholder value prior to entering into the agreement with KKR.  If you own WBMD shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/webmd-health-corp/

 

View original content:http://www.prnewswire.com/news-releases/weisslaw-llp-webmd-health-corp-acquisition-is-the-subject-of-a-legal-investigation-300493781.html

SOURCE WeissLaw LLP

Copyright 2017 PR Newswire

1 Year Webmd Health Chart

1 Year Webmd Health Chart

1 Month Webmd Health Chart

1 Month Webmd Health Chart

Your Recent History

Delayed Upgrade Clock